Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 121-132 of 2001 results.
"In patients with CIF and prior CRBSI, 1.35% taurolidine is a clinically superior and cost-saving secondary prevention strategy that reduces recurrent CRBSIs, CVC removals, and hospital resource use" Nerstrøm et al (2026).
A new Open Access publication on Femoral artery cannulation for arterial pressure measurement in the intensive care unit: current evidence and description of the technique…
"Catheter-related superficial venous thrombosis (SVT) of the upper extremity is a frequent complication of peripheral venous cannulation and longer peripheral devices such as midline catheters and peripherally inserted central catheters (PICCs)" Siniscalchi et al (2026).
"Maladministration events occurred infrequently and were predominantly associated with diagnostic procedures, with minimal patient harm in most cases. In contrast, extravasation and toxicity related to therapeutic radiopharmaceuticals, particularly high-energy beta emitters, carried greater clinical significance" Sutaşır et al (2026).
"Existing CRBSI prediction models demonstrate good discriminatory ability and clinical applicability. Identified risk factors can inform clinical early warning systems. However, methodological limitations and lack of external validation constrain current evidence" Liu et al (2026).
"We evaluated an Epic-based outpatient parenteral antimicrobial therapy (OPAT) order set to assess its impact on clinical workflows and analytics" Alsafadi et al (2026).
"To systematically evaluate the application value and implementation effectiveness of a Failure Mode and Effects Analysis (FMEA)-based bundled management strategy in the precise prevention and control of hospital-acquired infections (HAIs) in the Intensive Care Unit (ICU) of a specialized oncology hospital" Zhang et al (2026).
"The current vancomycin dosing protocol at HPSF does not consistently achieve therapeutic SVC in HD patients with CRBSI" Abd Majid et al (2026).
"Care bundles are associated with meaningful reductions in CLABSI rates in PICUs. Although most studies lack rigorous design, the consistent improvements observed support their effectiveness" Rosenvald et al (2026).
"VFA/TAMAI ratio serves as a valuable predictor of organ damage following CRBSI treatment in ECF patients, potentially enabling risk stratification and personalized management strategies" Yu et al (2026).
"Although often used off label, hypodermoclysis is a safe and practical alternative to IV infusion, particularly suitable for older or frail patients at home or in nursing homes. It offers a timely and pragmatic solution to issues related to outpatient care and hospital overcrowding" Arcani et al (2026).
"This study can inform the design of a definitive trial to assess the clinical and economic effectiveness of CHG-impregnated dressings for PIVCs, including refinement of the eligibility criteria and primary outcome" Drugeon et al (2026).
